Scott Milstein
Family Medicine · Milton, DENPI 1922113034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,596 and has fallen 72.8% since, to $707 in 2025.
Across 292 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Johnson & Johnson$920
- Novo Nordisk$684
- Amgen$470
- Lilly USA, LLC$469
- Amarin Pharma, Inc.$403
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,039100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 51 | $1,114 |
| Johnson & Johnson | 46 | $920 |
| Novo Nordisk | 33 | $684 |
| Amgen | 18 | $470 |
| Lilly USA, LLC | 27 | $469 |
| Amarin Pharma, Inc. | 20 | $403 |
| GSK | 21 | $287 |
| Astellas Pharma US Inc | 13 | $224 |
| Merck | 16 | $218 |
| Kowa Pharmaceuticals America, Inc. | 14 | $215 |
| E.r. Squibb & Sons, L.L.C. | 6 | $188 |
| Bolton Medical Inc | 1 | $150 |
| Boston Scientific | 1 | $150 |
| Boehringer Ingelheim | 8 | $117 |
| Dexcom, Inc. | 2 | $113 |
| Medtronic | 1 | $94 |
| Pfizer | 3 | $52 |
| Exact Sciences | 1 | $30 |
| Teleflex LLC | 1 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Philips North America LLC | 1 | $17 |
| Bayer | 1 | $16 |
| AbbVie | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$236
- TREO ABDOMINAL STENT-GRAFT SYSTEM$150
- ENROUTE Transcarotid Neuroprotection System$150
- ELIQUIS$123
- Repatha$123
- BREZTRI$121
- XARELTO$117
- AIMOVIG$116
- FARXIGA$114
How this compares
$6,059 in reported general payments places this provider in the 85th percentile of 352 family medicine providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisinopril | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Milton
- Bryan Patrick VillarMilton$3K
- Gregory PapaNew Castle$67K
- Sarah MullinsWilmington$36K
- Ashley PanichelliWilmington$27K
- Michelle PapaNewark$23K
- Maryann ConnorWilmington$21K
- Jill MackeyWilmington$20K
- Wayne TuckerBear$20K
- Ian MyersNewark$17K
- Glenn HamiltonWilmington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.